Aceto (NASDAQ:ACET) announced its quarterly earnings data on Thursday. The company reported ($0.59) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.54), RTT News reports. The firm had revenue of $164.41 million for the quarter. Aceto had a negative net margin of 34.41% and a positive return on equity of 0.55%. During the same quarter last year, the company posted $0.30 earnings per share.
Shares of NASDAQ ACET traded down $0.23 during trading hours on Friday, reaching $1.80. 996,398 shares of the stock traded hands, compared to its average volume of 252,886. The stock has a market cap of $63.14 million, a price-to-earnings ratio of 45.00 and a beta of 1.58. The company has a current ratio of 1.66, a quick ratio of 1.21 and a debt-to-equity ratio of 3.18. Aceto has a 52-week low of $1.53 and a 52-week high of $11.98.
In related news, Chairman Albert L. Eilender sold 10,700 shares of the firm’s stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $3.29, for a total transaction of $35,203.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Over the last three months, insiders have sold 32,187 shares of company stock worth $102,225. 4.10% of the stock is currently owned by insiders.
WARNING: “Aceto (ACET) Releases Earnings Results, Misses Estimates By $0.54 EPS” was published by WKRB News and is owned by of WKRB News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.wkrb13.com/2018/11/10/aceto-acet-releases-earnings-results-misses-estimates-by-0-54-eps.html.
Aceto Corporation engages in the development, marketing, sale, and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals, and agricultural protection products. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals.
See Also: Understanding Stock Ratings
Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.